e.g. mhealth
Search Results (1 to 10 of 103 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 27 Journal of Medical Internet Research
- 22 JMIR Research Protocols
- 16 JMIR Formative Research
- 14 JMIR mHealth and uHealth
- 6 JMIR Human Factors
- 5 JMIR Medical Informatics
- 2 Interactive Journal of Medical Research
- 2 JMIR Public Health and Surveillance
- 2 JMIR Rehabilitation and Assistive Technologies
- 2 JMIR Serious Games
- 1 JMIR AI
- 1 JMIR Aging
- 1 JMIR Biomedical Engineering
- 1 JMIR Nursing
- 1 Journal of Participatory Medicine
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Mental Health
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Perioperative Medicine
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Moreover, MOOCs can contribute to developing nurses’ skills, specifically in training for self-management of noncommunicable chronic diseases such as chronic obstructive pulmonary disease (COPD).
MOOCs are based on the definition of various concepts such as e-learning, mass communication, knowledge sharing, and openness [17]. MOOCs comprise quality content and aim at a large target audience, overcoming many of the in-class barriers [9].
JMIR Nursing 2025;8:e72957
Download Citation: END BibTex RIS
In addition, HRVs are implicated in the development of lower respiratory tract diseases, such as pneumonia, bronchitis, and bronchiolitis [1], as well as in the exacerbation of asthma [3] and chronic obstructive pulmonary disease (COPD) [4].
The susceptibility to severe HRV infections and reinfections is influenced by a range of environmental and genetic factors, including impaired interferon responses and pre-existing conditions namely asthma and COPD [5].
JMIR Res Protoc 2025;14:e73383
Download Citation: END BibTex RIS
This was emphasized in the study by Cox and Holland [27] who concluded that one size does not fit all, and more research is needed on different models of telerehabilitation in people with COPD to reach evidence-based consensus and increase possibilities for individualization [16,28].
To promote health, provide individualized treatment, and increase access to evidence-based treatment for people with COPD in Sweden, we developed an e Health tool for PR, Me&COPD (Swedish: Min KOL).
JMIR Form Res 2025;9:e68195
Download Citation: END BibTex RIS
This study aimed to thoroughly explore perspectives on COPD care processes, exacerbation management, and RPM in the Netherlands through following 3 objectives: (1) identify stakeholders involved in COPD exacerbation care, (2) understand existing COPD care with an explicit focus on exacerbations, and (3) explore stakeholder experiences and expectations regarding RPM in COPD care.
J Med Internet Res 2025;27:e67666
Download Citation: END BibTex RIS
Airway obstruction or stenosis, cough, dyspnea, and poor respiratory coordination make it difficult for patients with COPD to use inhalers properly [10]. A systematic evaluation of 144 inhaler technique observation reports indicates that only 31% (95% CI 28%-35%) of patients with COPD demonstrated the best inhaler technique in the past 4 decades [11].
J Med Internet Res 2025;27:e65309
Download Citation: END BibTex RIS
COPD exacerbations are defined as acute events described by a worsening of respiratory symptoms that are beyond normal day-to-day variations [1,2]. COPD exacerbations are the most frequent presentation in the hospital setting, both nationally and internationally. This accounts for a substantial economic burden [2,3]; for instance, within the European Union, COPD accounts for 56% of the overall respiratory costs annually [4].
JMIR Mhealth Uhealth 2025;13:e56318
Download Citation: END BibTex RIS
Chronic obstructive pulmonary disease (COPD) is a common disabling lung condition characterized by chronic respiratory symptoms that cause persistent, mostly progressive airflow limitations [1]. It is one of the major issues of public health, and its prevalence, mortality, and morbidity are increasing [1-3]. COPD was listed as the third leading cause of death worldwide in 2019 [4], and it is estimated that by 2040, deaths from COPD will rise to 4.4 million per year [5].
J Med Internet Res 2025;27:e57649
Download Citation: END BibTex RIS
Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) due to abnormalities of the airways (bronchitis and bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction [1,2]. In the Netherlands, 545,900 people experienced COPD in 2022.
JMIR Form Res 2025;9:e59533
Download Citation: END BibTex RIS
Chronic obstructive pulmonary disease (COPD) is a public health epidemic. The current state of the art displays a high prevalence and high burden [1]. COPD is the fourth leading cause of death worldwide, accounting for 3.5 million deaths in 2021, approximately 5% of all global deaths [2].
JMIR Public Health Surveill 2025;11:e66179
Download Citation: END BibTex RIS
Chronic obstructive pulmonary disease (COPD) is a major subset of chronic pulmonary diseases, with nearly 36% of patients developing comorbidities, such as hypertension and cardiovascular diseases [7]. Globally, 1 person succumbs to COPD every 10 seconds; in Taiwan, over 5000 deaths are attributed to COPD annually [8]. Severe cases of COPD may lead to systemic manifestations, emphasizing the urgency of interventions [9,10].
JMIR Hum Factors 2024;11:e60049
Download Citation: END BibTex RIS